Coagulation is the process, by which blood changes from a liquid to a gel, forming a blood clot. In general terms, coagulation is a process in which the blood forms clots to block and then heal a lesion/wound/cut and stop the bleeding.

The global Blood Coagulants market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Blood Coagulants volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood Coagulants market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Blood Coagulants in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Blood Coagulants manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Bayer
Novo Nordisk
Shire
SOBI
Octapharma
CSL
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Recombinant coagulation factor
Plasma coagulation factor

Segment by Application
Hospital
Pharmacy
Other